Favorable Clinical Course of Patients Experiencing Bevacizumab-Induced Proteinuria

Publisher： Karger

E-ISSN： 1662-6575|3|3|368-371

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.3, Iss.3, 2010-10, pp. : 368-371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab‐induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1456-1462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Course of Patients with Coronary Ectasia

By  

Cardiology, Vol. 91, Iss. 3, 1999-09 ,pp. : 145-149

Karger

Access to resources Recommend Favorite

Clinical Course of Pulmonary Embolism in Lung Cancer Patients

By  

Respiration, Vol. 78, Iss. 1, 2008-11 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

The clinical course of patients with septic abortion admitted to an intensive care unit

By Finkielman Javier   Feo Fabián   Heller Paula   Afessa Bekele  

Intensive Care Medicine, Vol. 30, Iss. 6, 2004-06 ,pp. : 1097-1102

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Course and Management of Patients Undergoing Open Window Thoracostomy for Thoracic Empyema

By  

Respiration, Vol. 68, Iss. 6, 2001-12 ,pp. : 606-610

Karger

Access to resources Recommend Favorite